The News Review:

- Medical clinical research slows for lack of patients
- Velos Inc. Appoints William Broucek Senior Director Professional …
- Investigational Drug May Help Avert Blood Clots
- Michael Brown MD Ph.D. and Judy Brown Research Consultants …

Medical clinical research slows for lack of patients
Los Angeles Times
James Thomas director of clinical trials at the hio State University Comprehensive Cancer Center says some insurance policies don’t pay for blood tests scans or examinations linked to the treatment. Medical clinical research slows for lack of patientsJay LaPrete For The TimesDr. James Thomas director of clinical trials at the hio State University Comprehensive Cancer Center says some insurance policies don’t pay for blood tests scans or examinations linked to the treatment. Enrollment shortages have delayed or canceled trials on experimental therapies. Researchers are trying to reverse that trend in part by using databases to connect patients with possible new cures.

Velos Inc. Appoints William Broucek Senior Director Professional …
FXBusiness
Velos developed this role to address needs coming out of its significant growth during the past two years. Broucek was hired to ensure that superior customer service is sustained while its market leadership continues to expand. “Excellence in meeting the singular needs of each customer has to keep pace with the excellence and reputation of our clinical research software product suite” said John S. McIlwain President and CE of Velos. “Broucek is safeguarding that objective as he oversees and directs our front line project managers supporting them with strong technical expertise and resources. ” Broucek is a healthcare software professional with proven success leading professional services and operations groups to complete implementation projects of all sizes on time and within budget. Previously Broucek held senior positions in professional services and implementation management with Bay Area companies that include Agistix iKnowMed a Division of US ncology acis Healthcare Systems and Fritz Companies Inc.

Investigational Drug May Help Avert Blood Clots
U.S. News & World Report
The trial included 1030 people 45 years and older who were scheduled to undergo either percutaneous coronary intervention (PCI) — a procedure to clear clogged arteries and keep them open with stents — or angiography and then PCI. People having PCI are usually prescribed drugs such as aspirin or clopidogrel to prevent potentially dangerous blood clots. The study participants were randomly assigned to receive one of three doses (10 20 or 40 milligrams) of the new drug called SCH 530348 or a placebo. Aspirin and clopidogrel were not prescribed as part of the study but were allowed and 95 percent of people in the study took both drugs the researchers said.

Michael Brown MD Ph.D. and Judy Brown Research Consultants …
MSNBC
Brown previously served as Bioheart’s Chief Scientific fficer and Vice President of Clinical Affairs from 1999 to 2004 and as a consulting Senior Clinical Specialist from January 2005 to December 2006. Prior to that he was a clinical specialist at Medtronic Inc. Judy Brown was previously Director of Clinical Research at World Medical Manufacturing Corporation from May 1998 to August 2000 and served as a consultant for World Medical in 2001. Prior to this work she coordinated clinical trials at the Baptist Cardiac & Vascular Institute Miami from 1990 to 1997. Her prior experience was in basic science research at the University of Miami where the two met. They have 40 years of combined basic science and clinical research management experience between them.
Related from Thebreakpage: Jim Brown wants to see the dancing stop